This little-known biotech could have a big hit on its hands with VK2735, a GLP-1 weight loss drug candidate.

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...

R3 Bio has a bold idea for replacing lab animals: genetically-engineered whole organ systems that lack a brain. The long-term ...

This Women's History Month, meet Ritu Shah as she shares her journey from being a chemical engineering student to becoming ...

The panel, made up of decision-makers at major investment firms, ran through the best ways to get past the first meeting with ...

The US Food and Drug Administration (FDA) has warned a biotech company about claims that its bladder cancer drug could treat and prevent multiple types of cance ...

Claflin University is building a biotech innovation center to offer students hands-on experiences in emerging fields, backed by $17 million in federal funding.

BIO-Europe Spring 2026 brought together more than 3,700 innovators in the life sciences industry all under the same roof.

A new initiative from BioIndustry Association and AstraZeneca aims to boost representation on heavily dominated male boards.

Oral peptide specialist Pinnacle Medicines has secured an $89 million series B with backing from investors in the U.S. and ...

Federal health officials issued a warning Tuesday over misleading statements made by biotech billionaire Dr. Patrick Soon-Shiong, who recently told podcast listeners that his company’s bladder cancer ...

The University of Texas at Arlington, a Carnegie R1 research institution, continues to expand its research capabilities as ...